sábado, 22 de septiembre de 2018

How one pharmaceutical company is reinventing the clinical trial - STAT

How one pharmaceutical company is reinventing the clinical trial - STAT

Daily Recap

Opinion: How one pharmaceutical company is reinventing the clinical trial

By ANDREAS KOESTER


ADOBE
Challenges abound for clinical trials, slowing them down and lengthening the drug development process. New approaches can revitalize the process.

No hay comentarios: